🇺🇸 FDA
Patent

US 10894033

Multicyclic compounds and methods of use thereof

granted A61KA61K31/381A61K31/435

Quick answer

US patent 10894033 (Multicyclic compounds and methods of use thereof) held by PGI Drug Discovery LLC expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/381, A61K31/435, A61K31/55, A61K45/06